{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:24:25Z","timestamp":1778498665817,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015398","name":"Spinal Muscular Atrophy UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.nmd.2021.01.008","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T20:40:54Z","timestamp":1611261654000},"page":"300-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A new respiratory scoring system for evaluation of respiratory outcomes in children with spinal muscular atrophy type1 (SMA1) on SMN enhancing drugs"],"prefix":"10.1016","volume":"31","author":[{"given":"L","family":"Edel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Grime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Manzur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Munot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Ridout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Scoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nmd.2021.01.008_bib0001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0883073816671236","article-title":"Spinal Muscular atrophy type I: is it ethical to standardize supportive care intervention in clinical trials?","volume":"32","author":"Finkel","year":"2017","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.nmd.2021.01.008_bib0002","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","volume":"28","author":"Calucho","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.01.008_bib0003","first-page":"3","article-title":"New and developing therapies in spinal muscular atrophy","volume":"28","author":"Kariyawasam","year":"2018","journal-title":"Paediatr Respir Rev"},{"issue":"9","key":"10.1016\/j.nmd.2021.01.008_bib0004","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40261-017-0557-5","article-title":"Nusinersen: the first option beyond supportive care for spinal muscular atrophy","volume":"37","author":"Maharshi","year":"2017","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.nmd.2021.01.008_bib0005","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","article-title":"Spinal muscular atrophy","volume":"33","author":"Kolb","year":"2015","journal-title":"Neurol Clin,"},{"issue":"1","key":"10.1016\/j.nmd.2021.01.008_bib0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2017.09.015","article-title":"Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy","volume":"28","author":"De Sanctis","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2021.01.008_bib0007","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.prrv.2007.11.003","article-title":"The use of mechanical ventilation is appropriate in children with genetically proven spinal muscular atrophy type 1: the motion for","volume":"9","author":"Bach","year":"2008","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1016\/j.nmd.2021.01.008_bib0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"Arnold","year":"2015","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nmd.2021.01.008_bib0009","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/JND-180315","article-title":"Evaluation of children with SMA type 1 under treatment with nusinersen within the expanded access program in Germany","volume":"5","author":"Pechmann","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"9","key":"10.1016\/j.nmd.2021.01.008_bib0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/gt.2017.52","article-title":"The clinical landscape for SMA in a new therapeutic era","volume":"24","author":"Talbot","year":"2017","journal-title":"Gene Ther"},{"issue":"3","key":"10.1016\/j.nmd.2021.01.008_bib0011","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.pcl.2015.03.010","article-title":"Spinal muscular atrophies","volume":"62","author":"Darras","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.nmd.2021.01.008_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2019.12.047","article-title":"Respiratory needs in patients with type 1 spinal muscular atrophy treated with nusinersen","author":"Sansone","year":"2020","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.nmd.2021.01.008_bib0013","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2021.01.008_bib0014","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.24864","article-title":"Emerging therapies and challenges in spinal muscular atrophy","volume":"81","author":"Farrar","year":"2017","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2021.01.008_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2021.01.008_bib0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.prrv.2009.10.007","article-title":"Airway clearance modalities in neuromuscular disease","volume":"11","author":"Finder","year":"2010","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.nmd.2021.01.008_bib0017","first-page":"69","article-title":"The clinical use of mechanical insufflation-exsufflation in children with neuromuscular disorders in Europe","volume":"27","author":"Hov","year":"2018","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"10.1016\/j.nmd.2021.01.008_bib0018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1479972314562209","article-title":"Mechanical insufflation\/exsufflation improves vital capacity in neuromuscular disorders","volume":"12","author":"Stehling","year":"2015","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.nmd.2021.01.008_bib0019","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.rmed.2018.01.012","article-title":"Airway clearance techniques in neuromuscular disorders: a state of the art review","volume":"136","author":"Chatwin","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.nmd.2021.01.008_bib0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.nmd.2017.10.008","article-title":"228th ENMC International Workshop: airway clearance techniques in neuromuscular disorders Naarden, The Netherlands, 3-5 March 2017","volume":"28","author":"Toussaint","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"Suppl 4","key":"10.1016\/j.nmd.2021.01.008_bib0021","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1542\/peds.2008-2952K","article-title":"Special considerations in the respiratory management of spinal muscular atrophy","volume":"123","author":"Schroth","year":"2009","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.nmd.2021.01.008_bib0022","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.PHM.0000083669.22483.04","article-title":"Prevention of pectus excavatum for children with spinal muscular atrophy Type 1","volume":"82","author":"Bach","year":"2003","journal-title":"Am J Phys Med Rehab"},{"issue":"11","key":"10.1016\/j.nmd.2021.01.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165818","article-title":"Spontaneous breathing pattern as respiratory functional outcome in children with spinal muscular atrophy (SMA)","volume":"11","author":"LoMauro","year":"2016","journal-title":"PLoS ONE"},{"issue":"18","key":"10.1016\/j.nmd.2021.01.008_bib0024","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.nmd.2021.01.008_bib0025","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.nmd.2021.01.008_bib0026","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.nmd.2016.10.002","article-title":"Developmental milestones in type I spinal muscular atrophy","volume":"26","author":"De Sanctis","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.01.008_bib0027","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201906-1175LE","article-title":"Effect of Nusinersen on respiratory muscle function in different subtypes of type 1 spinal muscular atrophy","author":"LoMauro","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.nmd.2021.01.008_bib0028","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2012-201964","article-title":"British Thoracic Society guideline for respiratory management of children with neuromuscular weakness","volume":"67","author":"Hull","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.nmd.2021.01.008_bib0029","first-page":"11","article-title":"Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1","volume":"28","author":"Fitzgerald","year":"2018","journal-title":"Paediatr Respir Rev"},{"issue":"10","key":"10.1016\/j.nmd.2021.01.008_bib0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/adc.2009.166512","article-title":"Implementation of \"the consensus statement for the standard of care in spinal muscular atrophy\" when applied to infants with severe type 1 SMA in the UK","volume":"95","author":"Roper","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nmd.2021.01.008_bib0031","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fneur.2018.00703","article-title":"A new method for measuring bell-shaped chest induced by impaired ribcage muscles in spinal muscular atrophy children","volume":"9","author":"LoMauro","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2021.01.008_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resp.2014.03.001","article-title":"Alterations of thoraco-abdominal volumes and asynchronies in patients with spinal muscle atrophy type III","volume":"197","author":"LoMauro","year":"2014","journal-title":"Respir Physiol Neurobiol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:11Z","timestamp":1760775011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0960896621000092"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.01.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new respiratory scoring system for evaluation of respiratory outcomes in children with spinal muscular atrophy type1 (SMA1) on SMN enhancing drugs","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}